United States Companion Animal Pharmaceuticals Market Research Report to 2027 - by Indication, Animal Type, Distribution Channel and State - ResearchAndMarkets.com

The "Companion Animal Pharmaceuticals Market Research Report by Indication, by Animal Type, by Distribution Channel, by State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The United States Companion Animal Pharmaceuticals Market size was estimated at USD 2,174.32 million in 2020, is expected to reach USD 2,502.21 million in 2021, and is projected to grow at a CAGR of 11.95% to reach USD 4,794.07 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Companion Animal Pharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the United States Companion Animal Pharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Companion Animal Pharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the United States Companion Animal Pharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the United States Companion Animal Pharmaceuticals Market?

6. What is the market share of the leading vendors in the United States Companion Animal Pharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the United States Companion Animal Pharmaceuticals Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative Impact of COVID-19

6. Companion Animal Pharmaceuticals Market, by Indication

6.1. Introduction

6.2. Behavioral Disorders

6.3. Dermatologic Diseases

6.4. Infectious Diseases

6.5. Orthopedic Diseases

6.6. Pain

7. Companion Animal Pharmaceuticals Market, by Animal Type

7.1. Introduction

7.2. Cats

7.3. Dogs

7.4. Horses

8. Companion Animal Pharmaceuticals Market, by Distribution Channel

8.1. Introduction

8.2. Retail Pharmacies

8.3. Veterinary Clinics

8.4. Veterinary Hospitals

9. California Companion Animal Pharmaceuticals Market

10. Florida Companion Animal Pharmaceuticals Market

11. Illinois Companion Animal Pharmaceuticals Market

12. New York Companion Animal Pharmaceuticals Market

13. Ohio Companion Animal Pharmaceuticals Market

14. Pennsylvania Companion Animal Pharmaceuticals Market

15. Texas Companion Animal Pharmaceuticals Market

16. Competitive Landscape

16.1. FPNV Positioning Matrix

16.1.1. Quadrants

16.1.2. Business Strategy

16.1.3. Product Satisfaction

16.2. Market Ranking Analysis

16.3. Market Share Analysis, By Key Player

16.4. Competitive Scenario

16.4.1. Merger & Acquisition

16.4.2. Agreement, Collaboration, & Partnership

16.4.3. New Product Launch & Enhancement

16.4.4. Investment & Funding

16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles

17.1. Ashish Life Science Pvt. Ltd.

17.2. Boehringer Ingelheim GmbH

17.3. Ceva Sante Animale

17.4. Chanelle Pharma

17.5. Dechra Pharmaceuticals plc

17.6. Eco Animal Health Group plc

17.7. Elanco Animal Health Incorporated

17.8. Endovac Animal Health

17.9. Hipra

17.10. Indian Immunologicals Ltd.

17.11. Inovet

17.12. Kyoritsu Seiyaku

17.13. Lutim Pharma Pvt. Ltd.

17.14. Merck & Co. Inc.

17.15. Norbrook Holdings Limited

17.16. Tianjin Ringpu Bio-Technology Co. Ltd.

17.17. Vetoquinol S.A.

17.18. Virbac

17.19. Zoetis Inc.

17.20. Zydus Animal Health and Investments Limited

18. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/7yzri7

View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005748/en/